"denosumab" meaning in English

See denosumab in All languages combined, or Wiktionary

Noun

IPA: /dɪˈnɒs.jʊ.mab/ [Received-Pronunciation], /dɛnˈoʊ.səˌmæb/ [General-American], /dəˈnɑs.jəˌmæb/ [General-American]
Etymology: From arbitrary prefix den- + -os- (“bone”) + -umab (“human monoclonal antibody”). Etymology templates: {{af|en|-os-|-umab|t1=bone|t2=human monoclonal antibody}} -os- (“bone”) + -umab (“human monoclonal antibody”) Head templates: {{en-noun|-}} denosumab (uncountable)
  1. (pharmacology) A drug (trademarks Prolia and Xgera) that is a genetically engineered monoclonal antibody that reduces bone resorption and increases bone mass by inhibiting osteoclast formation and function and that is administered by injection to prevent fractures associated with osteoporosis and malignant tumors of bone and to treat hypercalcemia associated with various cancers. Wikipedia link: denosumab Tags: uncountable Categories (topical): Pharmaceutical drugs

Alternative forms

Download JSON data for denosumab meaning in English (2.6kB)

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "-os-",
        "3": "-umab",
        "t1": "bone",
        "t2": "human monoclonal antibody"
      },
      "expansion": "-os- (“bone”) + -umab (“human monoclonal antibody”)",
      "name": "af"
    }
  ],
  "etymology_text": "From arbitrary prefix den- + -os- (“bone”) + -umab (“human monoclonal antibody”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "denosumab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms interfixed with -os-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -umab",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "glosses": [
        "A drug (trademarks Prolia and Xgera) that is a genetically engineered monoclonal antibody that reduces bone resorption and increases bone mass by inhibiting osteoclast formation and function and that is administered by injection to prevent fractures associated with osteoporosis and malignant tumors of bone and to treat hypercalcemia associated with various cancers."
      ],
      "id": "en-denosumab-en-noun-7yy6TLbr",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "drug",
          "drug"
        ],
        [
          "genetically engineered",
          "genetically engineered"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "bone",
          "bone"
        ],
        [
          "osteoclast",
          "osteoclast"
        ],
        [
          "injection",
          "injection"
        ],
        [
          "fracture",
          "fracture"
        ],
        [
          "osteoporosis",
          "osteoporosis"
        ],
        [
          "malignant",
          "malignant"
        ],
        [
          "tumor",
          "tumor"
        ],
        [
          "hypercalcemia",
          "hypercalcemia"
        ],
        [
          "cancer",
          "cancer"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A drug (trademarks Prolia and Xgera) that is a genetically engineered monoclonal antibody that reduces bone resorption and increases bone mass by inhibiting osteoclast formation and function and that is administered by injection to prevent fractures associated with osteoporosis and malignant tumors of bone and to treat hypercalcemia associated with various cancers."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "denosumab"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/dɪˈnɒs.jʊ.mab/",
      "tags": [
        "Received-Pronunciation"
      ]
    },
    {
      "ipa": "/dɛnˈoʊ.səˌmæb/",
      "tags": [
        "General-American"
      ]
    },
    {
      "ipa": "/dəˈnɑs.jəˌmæb/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "denosumab"
}
{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "-os-",
        "3": "-umab",
        "t1": "bone",
        "t2": "human monoclonal antibody"
      },
      "expansion": "-os- (“bone”) + -umab (“human monoclonal antibody”)",
      "name": "af"
    }
  ],
  "etymology_text": "From arbitrary prefix den- + -os- (“bone”) + -umab (“human monoclonal antibody”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "denosumab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English 4-syllable words",
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English terms interfixed with -os-",
        "English terms suffixed with -umab",
        "English terms with IPA pronunciation",
        "English uncountable nouns",
        "en:Pharmaceutical drugs"
      ],
      "glosses": [
        "A drug (trademarks Prolia and Xgera) that is a genetically engineered monoclonal antibody that reduces bone resorption and increases bone mass by inhibiting osteoclast formation and function and that is administered by injection to prevent fractures associated with osteoporosis and malignant tumors of bone and to treat hypercalcemia associated with various cancers."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "drug",
          "drug"
        ],
        [
          "genetically engineered",
          "genetically engineered"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "bone",
          "bone"
        ],
        [
          "osteoclast",
          "osteoclast"
        ],
        [
          "injection",
          "injection"
        ],
        [
          "fracture",
          "fracture"
        ],
        [
          "osteoporosis",
          "osteoporosis"
        ],
        [
          "malignant",
          "malignant"
        ],
        [
          "tumor",
          "tumor"
        ],
        [
          "hypercalcemia",
          "hypercalcemia"
        ],
        [
          "cancer",
          "cancer"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A drug (trademarks Prolia and Xgera) that is a genetically engineered monoclonal antibody that reduces bone resorption and increases bone mass by inhibiting osteoclast formation and function and that is administered by injection to prevent fractures associated with osteoporosis and malignant tumors of bone and to treat hypercalcemia associated with various cancers."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "denosumab"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/dɪˈnɒs.jʊ.mab/",
      "tags": [
        "Received-Pronunciation"
      ]
    },
    {
      "ipa": "/dɛnˈoʊ.səˌmæb/",
      "tags": [
        "General-American"
      ]
    },
    {
      "ipa": "/dəˈnɑs.jəˌmæb/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "denosumab"
}

This page is a part of the kaikki.org machine-readable English dictionary. This dictionary is based on structured data extracted on 2024-04-22 from the enwiktionary dump dated 2024-04-21 using wiktextract (fc4f0c7 and c937495). The data shown on this site has been post-processed and various details (e.g., extra categories) removed, some information disambiguated, and additional data merged from other sources. See the raw data download page for the unprocessed wiktextract data.

If you use this data in academic research, please cite Tatu Ylonen: Wiktextract: Wiktionary as Machine-Readable Structured Data, Proceedings of the 13th Conference on Language Resources and Evaluation (LREC), pp. 1317-1325, Marseille, 20-25 June 2022. Linking to the relevant page(s) under https://kaikki.org would also be greatly appreciated.